PIPER SANDLER COMPANIES

PIPR

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
PIPR
CIK0001230245
SIC6211
SectorFinance, Insurance, And Real Estate
Industry CategoryTrading
Industry GroupSecurity And Commodity Brokers, Dealers, Exchanges & Services

Contact

Address800 NICOLLET MALL, SUITE 900, MINNEAPOLIS, MN, 55402
Website pipersandler.com
Phone(612) 303-6000
CEOChad R. Abraham
Employees1,790

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$1.72 billion
Pre-Tax Income$267.91 million
Net Income$203.50 million
Net Income to Common$236.42 million
EPS$13.29
View All
Balance Sheet
Cash$114.00 million
Assets$2.22 billion
Liabilities$756.66 million
Common Equity$1.28 billion
Liabilities & Equity$2.22 billion
View All
Cash Flow Statement
Calculations
NOPAT$203.50 million
EBITDA$317.98 million
Price to Earnings$26.65
Price to Book$4.91
ROE14.41%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

2 Growth Stocks with All-Star Potential and 1 We Turn Down

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.

Article Link

2 Profitable Stocks for Long-Term Investors and 1 That Underwhelm

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Article Link

Tompkins Financial Corporation Recognized as a Top-Performing Small-Cap Bank by Piper Sandler

ITHACA, N.Y., December 08, 2025--Tompkins Financial Corporation (NYSE American: TMP) is proud to announce its inclusion in the prestigious Piper Sandler "Sm-All Stars" list, which highlights Piper Sandler’s annual list of top-performing small-cap banks and thrifts. This recognition underscores Tompkins’ strong financial performance and disciplined execution of its long-term growth strategy.

Article Link

How the Narrative Surrounding Prothena Is Changing After New Pipeline and Valuation Updates

Prothena’s fair value estimate has been nudged higher from $18.33 to $20.33 per share as analysts grow more confident in the company’s partnered pipeline and its potential to drive stronger long term revenue. The model now assumes faster top line expansion, with projected revenue growth raised from 74.7% to 90.9%, reflecting optimism around milestones, royalties, and expanding indications. Read on to see how this evolving narrative is reshaping expectations for Prothena and how you can stay...

Article Link

March Biosciences Designates Dr. Gurpreet Ratra as Chief Business Officer

By Karen Roman March Biosciences said it appointed Gurpreet Ratra, Ph.D., as Chief Business Officer. Dr. Ratra has more than 25 years of experience in the life science industry including cell and gene therapy, as well as equity research leadership, the company stated. He previously served in companies such as Kate Therapeutics, Skyline TX and Spark […]

Article Link